Janet Peper

Title: Janet Peper: Innovator in Cancer Immunotherapy

Introduction

Janet Peper is a notable inventor based in Freising, Germany. She has made significant contributions to the field of immunotherapy, particularly in the fight against ovarian cancer and other malignancies. Her innovative work focuses on the development of peptides and their applications in cancer treatment.

Latest Patents

Janet Peper holds a patent for "Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers." This invention relates to peptides, proteins, nucleic acids, and cells utilized in immunotherapeutic methods. Specifically, it addresses the immunotherapy of cancer by introducing tumor-associated T-cell peptide epitopes. These epitopes can serve as active pharmaceutical ingredients in vaccine compositions that stimulate anti-tumor immune responses. Additionally, the invention discusses the potential of peptides bound to major histocompatibility complex (MHC) molecules as targets for antibodies and other binding molecules.

Career Highlights

Throughout her career, Janet has worked with prominent companies in the pharmaceutical industry, including Pieris Pharmaceuticals GmbH and Les Laboratoires Servier. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in cancer immunotherapy.

Collaborations

Janet has collaborated with notable professionals such as Heiko Schuster and Kevin Röhle. These partnerships have further enhanced her research and development efforts in the area of immunotherapy.

Conclusion

Janet Peper's innovative work in cancer immunotherapy exemplifies her commitment to advancing medical science. Her contributions through patents and collaborations highlight her role as a key figure in the fight against cancer.